Swiss All Share Index
17.109,33
PKT
+109,81
PKT
+0,65
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.04.06 | Novartis overweight | Prudential Financial | |
| 24.04.06 | Novartis akkumulieren | Independent Research | |
| 24.04.06 | Novartis akkumulieren | Pacific Continental Sec. | |
| 25.04.06 | Nestlé overweight | Lehman Brothers | |
| 26.04.06 | Novartis buy | Bank Sarasin & Cie | |
| 21.04.06 | UBS | DZ-Bank | |
| 20.04.06 | Novartis buy | Merrill Lynch | |
| 20.04.06 | Novartis | Weberbank | |
| 13.04.06 | UBS | DZ-Bank | |
| 18.04.06 | Swiss Life kaufen | Nord LB | |
| 13.04.06 | Swatch (I) | Focus Money | |
| 11.04.06 | Swiss Life buy | Merrill Lynch | |
| 11.04.06 | Swiss Life kaufen | Bankhaus Lampe | |
| 11.04.06 | UBS akkumulieren | Independent Research | |
| 10.04.06 | UBS halten | Pacific Continental Sec. | |
| 10.04.06 | Givaudan akkumulieren | Pacific Continental Sec. | |
| 07.04.06 | UBS | DZ-Bank | |
| 11.04.06 | Novartis buy | Jyske Bank | |
| 07.04.06 | Novartis buy | Citigroup | |
| 06.04.06 | Novartis | Weberbank | |
| 06.04.06 | UBS | Zürcher Kantonalbank | |
| 06.04.06 | Schindler | Zürcher Kantonalbank | |
| 11.04.06 | Holcim halten | Helaba Trust | |
| 06.04.06 | Novartis buy | UBS | |
| 05.04.06 | Novartis akkumulieren | Independent Research | |
| 04.04.06 | Schindler overweight | JP Morgan | |
| 04.04.06 | Novartis buy | Merrill Lynch | |
| 04.04.06 | Nestlé buy | Merrill Lynch | |
| 04.04.06 | Zurich Insurance akkumulieren | Pacific Continental Sec. | |
| 04.04.06 | Holcim kaufen | Helaba Trust | |
| 05.04.06 | Swatch (I) buy | Merrill Lynch | |
| 31.03.06 | UBS | DZ-Bank | |
| 31.03.06 | Swiss Life kaufen | M.M. Warburg | |
| 31.03.06 | Novartis | Der Aktionärsbrief | |
| 31.03.06 | Swiss Life Outperformer | LB Rheinland-Pfalz | |
| 04.04.06 | Novartis buy | Jyske Bank | |
| 30.03.06 | Swiss Life hold | WestLB | |
| 30.03.06 | Swatch (I) | Zürcher Kantonalbank | |
| 30.03.06 | Holcim verkaufen | Helaba Trust | |
| 29.03.06 | Novartis buy | Merrill Lynch |